Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
- 16 November 2017
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 50 (5), 1701248
- https://doi.org/10.1183/13993003.01248-2017
Abstract
Donor-specific antibodies (DSAs) against human leukocyte antigen (HLA) are associated with chronic lung allograft dysfunction (CLAD) and mortality post lung transplantation, but data concerning prevalence, time of onset, persistence and effects on long-term outcome remain scarce. We assessed the association between HLA antibodies and CLAD-free and graft survival in a cohort of 362 patients. We stratified our analysis according to DSA status, persistence of antibodies and timing of antibodies (pre-transplant, early or late post-transplant). Within our cohort, 61 (17%) patients developed DSAs (mostly against HLA-DQ), which was associated with worse CLAD-free and graft survival (p<0.0001 and p=0.059, respectively). Persistent (hazard ratio (HR) 3.386, 95% CI 1.928–5.948; p<0.0001) as well as transient (HR 2.998, 95% CI 1.406–6.393; p=0.0045) DSAs were associated with shorter CLAD-free survival compared with patients without DSAs. Persistent DSAs (HR 3.071, 95% CI 1.632–5.778; p=0.0005) but not transient DSAs were negatively associated with graft survival compared with patients without DSAs, likely due to the higher incidence of restrictive CLAD. HLA non-DSAs and pre-transplant HLA antibodies had no effect on post-transplant outcome. We demonstrated an important difference in prognosis between persistent and transient DSAs. Moreover, the observed association between DSAs and restrictive CLAD suggests an overlap between antibody-mediated rejection and restrictive CLAD that needs further investigation.Funding Information
- KU Leuven (C24/15/030)
- Fonds Wetenschappelijk Onderzoek (12G8715N, 1515816N)
This publication has 22 references indexed in Scilit:
- High-dose vitamin D after lung transplantation: A randomized trialThe Journal of Heart and Lung Transplantation, 2017
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart–Lung Transplant Report—2016; Focus Theme: Primary Diagnostic Indications for TransplantThe Journal of Heart and Lung Transplantation, 2016
- De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung TransplantationThe Journal of Heart and Lung Transplantation, 2016
- Restrictive chronic lung allograft dysfunction: Where are we now?The Journal of Heart and Lung Transplantation, 2015
- De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- A new classification system for chronic lung allograft dysfunctionThe Journal of Heart and Lung Transplantation, 2014
- Implications for Human Leukocyte Antigen Antibodies After Lung TransplantationChest, 2013
- The collaborative transplant study registryTransplantation Reviews, 2013